Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study.

NCT07400809 is registered in ClinicalTrials.gov with Tata Memorial Hospital as lead sponsor.

NCT NCT07400809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07400809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study.
Lead sponsor
Tata Memorial Hospital
Phase
Observational
Overall status
Recruiting
Start date
August 23, 2023
Completion date
June 14, 2027
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervix cancer, chemotherapy, metastasis, radiotherapy, recurrent, surgery, treatment compliance